Second Sight President & CEO Robert Greenberg, MD, PhD looks back on Sec-ond Sight’s long road to getting FDA approval for Argus II and considers the path not taken.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
